Location: Home
  • search
  • go
  • Relate News
  • 8/26/2019SMEI: Top Chemical Drug Products in Urban Chinese Retail Pharmacies 20...
  • 8/26/2019IQVIA: Overall Chinese Pharma Market Growth Slowed to 4.5% in 2018
  • 8/26/2019Review of Chinese Drug Evaluation and Registration in 2018
  • 8/26/2019China Adopts New Amendment of PRC Drug Administration Law
  • 8/26/2019Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
  • 8/23/2019China Cites Old Data to Support Claim of Higher Birth Rates after Two-...
  • 8/23/2019Chi-Med Initiates Phase I Trial of HMPL-523 for Immune Thrombocytopeni...
  • 8/23/2019New Revision Draft of Drug Administration Law Submitted to the NPC for...
  • 8/23/2019111 Signs Strategic Partnership with TK.CN to Empower PBM and Insuranc...
  • 8/23/2019China to Step Up Crackdown on Drug Monopoly to Keep Prices and Supply ...
  • 8/22/2019CDE Publicizes 16 Drug Applications To Be Granted Priority Review Stat...
  • 8/22/2019Luye Pharma to Begin Trials of Anti-depression Drug in Japan as It Pro...
  • 8/21/2019Upcoming Event: Asia Biopharma Continuous Manufacturing & Process ...
  • 8/21/2019Study links pollution to increase in bipolar disorder, depression
  • 8/21/2019Roxadustat Approved in China for Treatment of Anemia in CKD Patients N...
  • 8/21/2019China's Biopharma Strategy: Challenge or Complement to U.S. Industry C...
  • 8/21/2019Innovent Enters a Licensing Agreement with Lilly to Develop & ...
  • 8/21/2019Alligator Bio and Biotheus Enter Antibody Agreement for Greater China
  • 8/21/2019Cancer Research Facilities Become A Target of Chinese Hackers
  • 8/21/2019USFDA Grants Priority Review to BeiGene's Zanubrutinib in Patients wit...
  • 8/21/2019Roche Granted Additional Indication for Its Breast Cancer Drug Perjeta
  • 8/21/2019CDE Accepts Clinical Trial Application of Gilead's NASH drug Selonsert...
  • 8/21/2019Cancer Treatment in China: The Underestimated Opportunity
  • 8/21/2019CMAB and Kintor Announce a New Partnership to Develop and Manufacture ...
  • 8/20/2019China's Central Government Introduces Major Policy Incentives and Rest...
  • 8/20/2019NHSA and MOHRSS Issue NRDL under the BMI, WRI and Maternity Insurance
  • 8/20/2019Chronic and Aging-related Diseases Cost Over Half of Chinese BMI Spend...
  • 8/19/2019NMPA Issues the Administrative Measures for Drug Quality Sampling Insp...
  • 8/19/2019CitiResearch - China at Inflection Point: Big Opportunity for MNCs, Do...
  • 8/19/2019Sanofi Gains Chinese IND Approval for RNAi Therapy Fitusiran Injection
  • Page:270/775 Total number of articles:23233: [First][<<] [268] [269] [270] [271] [272] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group